Deutsche Bank AG Has $86.98 Million Stake in Molina Healthcare, Inc (NYSE:MOH)

Deutsche Bank AG lessened its position in shares of Molina Healthcare, Inc (NYSE:MOH - Free Report) by 22.0% during the 1st quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 264,065 shares of the company's stock after selling 74,395 shares during the quarter. Deutsche Bank AG owned about 0.49% of Molina Healthcare worth $86,980,000 at the end of the most recent quarter.

Several other large investors have also made changes to their positions in MOH. Amalgamated Bank increased its holdings in shares of Molina Healthcare by 0.3% in the first quarter. Amalgamated Bank now owns 11,580 shares of the company's stock worth $3,814,000 after acquiring an additional 33 shares in the last quarter. Deseret Mutual Benefit Administrators increased its holdings in shares of Molina Healthcare by 60.7% in the first quarter. Deseret Mutual Benefit Administrators now owns 90 shares of the company's stock worth $30,000 after acquiring an additional 34 shares in the last quarter. JLB & Associates Inc. increased its holdings in shares of Molina Healthcare by 0.3% in the first quarter. JLB & Associates Inc. now owns 10,626 shares of the company's stock worth $3,500,000 after acquiring an additional 36 shares in the last quarter. Coldstream Capital Management Inc. increased its holdings in shares of Molina Healthcare by 2.1% in the fourth quarter. Coldstream Capital Management Inc. now owns 2,346 shares of the company's stock worth $683,000 after acquiring an additional 48 shares in the last quarter. Finally, Rothschild Investment LLC increased its holdings in shares of Molina Healthcare by 126.3% in the first quarter. Rothschild Investment LLC now owns 86 shares of the company's stock worth $28,000 after acquiring an additional 48 shares in the last quarter. Institutional investors and hedge funds own 98.50% of the company's stock.

Insider Activity at Molina Healthcare

In related news, COO James Woys purchased 10,000 shares of Molina Healthcare stock in a transaction that occurred on Monday, August 4th. The stock was purchased at an average cost of $155.94 per share, with a total value of $1,559,400.00. Following the completion of the transaction, the chief operating officer owned 74,331 shares of the company's stock, valued at approximately $11,591,176.14. This trade represents a 15.54% increase in their position. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, Director Ronna Romney sold 700 shares of the stock in a transaction that occurred on Wednesday, August 6th. The shares were sold at an average price of $153.74, for a total value of $107,618.00. Following the transaction, the director directly owned 17,131 shares of the company's stock, valued at $2,633,719.94. This trade represents a 3.93% decrease in their ownership of the stock. The disclosure for this sale can be found here. Corporate insiders own 1.26% of the company's stock.

Analyst Upgrades and Downgrades

Several equities research analysts have issued reports on the company. Mizuho lowered their price target on Molina Healthcare from $400.00 to $330.00 and set an "outperform" rating for the company in a report on Friday, July 11th. UBS Group lowered their price target on Molina Healthcare from $260.00 to $180.00 and set a "neutral" rating for the company in a report on Friday, July 25th. Cantor Fitzgerald restated a "neutral" rating and issued a $210.00 price target (down from $312.00) on shares of Molina Healthcare in a report on Friday, July 25th. Truist Financial reiterated a "hold" rating and set a $180.00 price objective (down from $335.00) on shares of Molina Healthcare in a report on Friday, July 25th. Finally, Robert W. Baird decreased their price objective on Molina Healthcare from $373.00 to $179.00 and set a "neutral" rating for the company in a report on Friday, July 25th. Eleven investment analysts have rated the stock with a hold rating and three have assigned a buy rating to the stock. According to data from MarketBeat.com, the stock currently has an average rating of "Hold" and a consensus target price of $244.55.

Molina Healthcare Stock Up 2.5%

NYSE MOH traded up $3.89 during trading hours on Wednesday, hitting $161.20. 1,313,426 shares of the company traded hands, compared to its average volume of 969,118. The business's 50-day moving average is $231.16 and its 200-day moving average is $284.81. Molina Healthcare, Inc has a twelve month low of $151.95 and a twelve month high of $365.23. The company has a debt-to-equity ratio of 0.77, a quick ratio of 1.66 and a current ratio of 1.66. The stock has a market capitalization of $8.74 billion, a price-to-earnings ratio of 7.94 and a beta of 0.52.

Molina Healthcare (NYSE:MOH - Get Free Report) last issued its quarterly earnings results on Wednesday, July 23rd. The company reported $5.48 EPS for the quarter, missing the consensus estimate of $5.50 by ($0.02). Molina Healthcare had a net margin of 2.60% and a return on equity of 27.72%. The company had revenue of $11.43 billion for the quarter, compared to analyst estimates of $10.94 billion. During the same period last year, the company posted $5.86 earnings per share. The business's revenue for the quarter was up 15.7% on a year-over-year basis. Sell-side analysts anticipate that Molina Healthcare, Inc will post 24.4 earnings per share for the current year.

About Molina Healthcare

Molina Healthcare, Inc provides managed healthcare services to low-income families and individuals under the Medicaid and Medicare programs and through the state insurance marketplaces. It operates in four segments: Medicaid, Medicare, Marketplace, and Other. The company served in across 19 states. The company was founded in 1980 and is headquartered in Long Beach, California.